Evidence map›Paper›PMID 35267132›Full record

ReviewJournal of neuro-oncology2022

Focused ultrasound for the treatment of glioblastoma.

Jill W Roberts, Lauren Powlovich, Natasha Sheybani, Suzanne LeBlang

Open access · hybridAbstract readReview
In one paragraph

Review in Journal of neuro-oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 3 pooled it
4.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 3 syntheses or guidelines pooled it, 60 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. Glioblastoma Therapy: Past, Present and Future.International journal of molecular sciences · 2024
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Jill W RobertsFocused Ultrasound Foundation, 1230 Cedars Court, Suite 206, Charlottesville, VA, 22903, USA. jroberts@fusfoundation.org.ORCID http://orcid.org/0000-0002-8404-8399
Lauren PowlovichFocused Ultrasound Foundation, 1230 Cedars Court, Suite 206, Charlottesville, VA, 22903, USA.ORCID http://orcid.org/0000-0002-4639-0345
Natasha SheybaniDepartment of Biomedical Engineering, University of Virginia, Charlottesville, VA, 22908, USA.ORCID http://orcid.org/0000-0002-1137-058X
Suzanne LeBlangFocused Ultrasound Foundation, 1230 Cedars Court, Suite 206, Charlottesville, VA, 22903, USA.ORCID http://orcid.org/0000-0001-7329-6138
Focused Ultrasound Foundation · USUniversity of Virginia · US

Funding

Immunoengineering Next-Generation Cancer Therapies with Focused UltrasoundDP5OD031846 · OD · UNIVERSITY OF VIRGINIA · PI SHEYBANI, NATASHA DIBA · 2021 to 2025
$2.0M
NIH HHS DP5 OD031846
6 · The paper itself

Abstract

purposeSix years ago, in 2015, the Focused Ultrasound Foundation sponsored a workshop to discuss, and subsequently transition the landscape, of focused ultrasound as a new therapy for treating glioblastoma.

methodsThis year, in 2021, a second workshop was held to review progress made in the field. Discussion topics included blood-brain barrier opening, thermal and nonthermal tumor ablation, immunotherapy, sonodynamic therapy, and desired focused ultrasound device improvements.

resultsThe outcome of the 2021 workshop was the creation of a new roadmap to address knowledge gaps and reduce the time it takes for focused ultrasound to become part of the treatment armamentarium and reach clinical adoption for the treatment of patients with glioblastoma. Priority projects identified in the roadmap include determining a well-defined algorithm to confirm and quantify drug delivery following blood-brain barrier opening, identifying a focused ultrasound-specific microbubble, exploring the role of focused ultrasound for liquid biopsy in glioblastoma, and making device modifications that better support clinical needs.

conclusionThis article reviews the key preclinical and clinical updates from the workshop, outlines next steps to research, and provides relevant references for focused ultrasound in the treatment of glioblastoma.

Indexed as

GlioblastomaUltrasonic TherapyBlood-Brain BarrierDrug Delivery SystemsHumansMicrobubblesBlood–brain barrier openingCancer immunotherapyFocused ultrasoundGlioblastomaHistotripsySonodynamic therapyTumor ablation

Identifiers

PMID35267132
PMCPMC9021052
OpenAlexW4221059405

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.